MicroRNAs in idiopathic childhood nephrotic syndrome

Bagga, Arvind

DOI: https://doi.org/10.1007/s10157-024-02595-3

IF: 2.6212

2024-12-05

Clinical and Experimental Nephrology

Abstract:miRNAs are non-coding RNA that are recognized as biomarkers of kidney disorders. There is limited information on the differential expression of miRNA and their target genes in idiopathic nephrotic syndrome of childhood.

urology & nephrology

What problem does this paper attempt to address?

Differentially Expressed Micrornas in Kidney Biopsies from Various Subtypes of Nephrotic Children.

Meiling Lu,Cheng Wang,Yunlong Yuan,Yuanyuan Zhu,Zhimin Yin,Zhengkun Xia,Chunni Zhang

DOI: https://doi.org/10.1016/j.yexmp.2015.10.003

IF: 4.401

2015-01-01

Experimental and Molecular Pathology

Abstract:Background: Our previous study showed a set of increased miRNAs in serum or urine from nephrotic syndrome children. In this study, we investigated the renal expression of these miRNAs in nephrotic children and explored their role in pathogenesis and as potential indicators to differentiate subtypes of kidney diseases.Methods: We enrolled 52 children with six different subtypes of nephropathy, and 8 normal kidney tissues were used as controls. RT-qPCR was used to quantify the expression of miR-191, miR-151-3p, miR-150, miR-30a-5p and miR-19b in renal tissues.Results: miR-191 and miR-151-3p exhibited significantly higher and lower intrarenal expression in all six subtypes of kidney diseases compared to controls. miR-19b was upregulated in three subtypes, and miR-30a-5p and miR-150 were downregulated in two and four subtypes, respectively. The intrarenal expression of miR-150 was significantly different between minimal change disease (MCD) and some other subtypes. The renal levels of these miRNAs correlated significantly with some renal functions and immune parameters. Bioinformatics showed that some target genes of these miRNAs were associated with immune and renal pathological changes.Conclusions: These five miRNAs may be involved in the pathogenesis of nephropathy in children. miR-150 is a potential typing indictor to differentiate MCD from other nephropathy subtypes. (C) 2015 Elsevier Inc. All rights reserved.
Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.

Yang Luo,Cheng Wang,Xi Chen,Tianying Zhong,Xiaoyi Cai,Sidi Chen,Yonghui Shi,Jing Hu,Xiaocui Guan,Zhengkun Xia,Junjun Wang,Ke Zen,Chen-Yu Zhang,Chunni Zhang

DOI: https://doi.org/10.1373/clinchem.2012.195297

IF: 12.114

2013-01-01

Clinical Chemistry

Abstract:BACKGROUND: MicroRNAs (miRNAs) are present in body fluids and may have the potential to serve as disease biomarkers. This study explored the clinical value of miRNAs in serum and urine as biomarkers for idiopathic childhood nephrotic syndrome (NS). METHODS: We obtained serum samples from 159 NS children (24 steroid resistant and 135 steroid sensitive), 109 age/sex-matched healthy controls and 44 children with other kidney diseases. Serum miRNAs were analyzed with the TaqMan Low Density Array and then validated with a quantitative reverse-transcription PCR assay with 126 individual samples. Moreover, we collected paired serum samples from 50 patients before and after treatment to determine the value of these miRNAs for condition assessment. In addition, urine samples from these patients were examined for candidate miRNAs. RESULTS: The concentrations of serum miR-30a-5p, miR-151-3p, miR-150, miR-191, and miR-19b were highly increased in NS children compared with controls (P < 0.0001). The urinary miR-30a-5p concentration was also increased in NS (P = 0.001). The area under the ROC curve and the odds ratio for the combined 5 serum miRNAs were 0.90 (95% CI, 0.86-0.94; P < 0.0001) and 40.7 (95% CI, 6.06 -103; P < 0.0001), respectively. Moreover, the concentrations of the 5 serum miRNAs and urinary miR-30a-5p markedly declined with the clinical improvement of the patients. CONCLUSIONS: We determined that 5 distinct serum miRNAs and urinary miR-30a-5p were increased in NS children. These circulating or urinary miRNAs may represent potential diagnostic and prognostic biomarkers for idiopathic pediatric NS. (C) 2013 American Association for Clinical Chemistry
Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Maria Angeles Baker,Seth J. Davis,Pengyuan Liu,Xiaoqing Pan,Anna Marie Williams,Kenneth A. Iczkowski,Sean T. Gallagher,Kaylee Bishop,Kevin R. Regner,Yong Liu,Mingyu Liang

DOI: https://doi.org/10.1681/asn.2016121280

IF: 14.978

2017-01-01

Journal of the American Society of Nephrology

Abstract:MicroRNAs contribute to the development of kidney disease. Previous analyses of microRNA expression in human kidneys, however, were limited by tissue heterogeneity or the inclusion of only one pathologic type. In this study, we used laser-capture microdissection to obtain glomeruli and proximal tubules from 98 human needle kidney biopsy specimens for microRNA expression analysis using deep sequencing. We analyzed specimens from patients with diabetic nephropathy (DN), FSGS, IgA nephropathy (IgAN), membranoproliferative GN (MPGN) (n=19-23 for each disease), and a control group (n=14). Compared with control glomeruli, DN, FSGS, IgAN, and MPGN glomeruli exhibited differential expression of 18, 12, two, and 17 known microRNAs, respectively. The expression of several microRNAs also differed between disease conditions. Specifically, compared with control or FSGS glomeruli, IgAN glomeruli exhibited downregulated expression of hsa-miR-3182. Furthermore, in combination, the expression levels of hsa-miR-146a-5p and hsa-miR-30a-5p distinguished DN from all other conditions except IgAN. Compared with control proximal tubules, DN, FSGS, IgAN, and MPGN proximal tubules had differential expression of 13, 14, eight, and eight microRNAs, respectively, but expression of microRNAs did not differ significantly between the disease conditions. The abundance of several microRNAs correlated with indexes of renal function. Finally, we validated the differential glomerular expression of select microRNAs in a second cohort of patients with DN (n=19) and FSGS (n=21). In conclusion, we identified tissue specific microRNA expression patterns associated with several kidney pathologies. The identified microRNAs could be developed as biomarkers of kidney diseases and might be involved in disease mechanisms.
Differential Expression Of Urinary Exosomal Small Rnas In Idiopathic Membranous Nephropathy

Jinshi Zhang,Yifan Zhu,Ruyi Cai,Juan Jin,Qiang He

DOI: https://doi.org/10.1155/2020/3170927

2020-01-01

BioMed Research International

Abstract:Background. Idiopathic membranous nephropathy (IMN) is a major cause of adult nephrotic syndromes, and reliable noninvasive biomarkers for diagnosis and monitoring are urgently needed. In this study, we performed small RNA (sRNA) sequencing to explore sRNA profiles of urinary exosomes derived from IMN patients and healthy controls (CON) to provide clues for identifying novel noninvasive sRNA biomarkers for IMN. Methods. Urine samples were collected from five healthy controls and six patients with IMN. High-throughput sequencing was used to screen sRNA expression profiles of urinary exosomes from patients with IMN in two independent cohorts. Results. Urinary exosomes were successfully isolated and used to obtain exosomal sRNAs. We screened 131 differentially expressed miRNAs, including 28 specifically expressed miRNAs, then explored the top 10 specifically expressed miRNAs in all IMN individuals. The specifically expressed miRNAs and differentially expressed miRNAs provide potential biomarkers for IMN. Additionally, we discovered numerous sRNAs derived from genomic repetitive sequences, which could represent an exciting new area of research. Conclusion. Herein, we revealed significant differences in expression profiles of urinary exosomal miRNAs and repetitive region-derived sRNAs between patients with IMN and healthy controls. The findings could facilitate the development of potential molecular targets for membranous nephropathy.
Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Jun LUO,Mei-ling LU,Cheng WANG,Zheng-kun XIA,Chun-ni ZHANG

DOI: https://doi.org/10.13602/j.cnki.jcls.2017.08.10

2017-01-01

Abstract:Objective To investigate the expression levels of miRNA in kidney biopsies of child patients with nephrotic syndrome and the possibility of miRNA as potential markers in differentiating the pathologic subtypes of nephrosis.Methods Kidney biopsy specimens from 41 child patients with nephrotic syndrome,including 22 with nesangial proliferative glomeplonephritis (MsPGN),8 with minimal change disease (MCD) and 11 with endocapillary proliferative glomerulonephritis (ECPGN),were collected,and adult nephridial tissues from 8 patients without renal inadequacy were selected as controls.The expression levels of miR-191,miR-151-3p,miR-150,miR-30a-5p and miR-19b in nephridial tissues were detected by RT-qPCR,and their correlations with renal function related parameters were analyzed.Results Compared with the controls,the miR-191 levels in kidney tissues of child patients with nephrotic syndrome increased significantly (P ＜ 0.01),while the miR-151-3p levels decreased obviously (P ＜ 0.01).The expression levels of miR-150 in MCD patients were significantly lower than those in MsPGN and ECPGN patients and the controls (P ＜ 0.05).The expression levels of these miRNAs were positively correlated with serum IgG,TP and Cr levels,but negatively with serum TC levels (P ＜0.05).Conclusion The expression levels of miRNA in kidney tissues of child patients with nephrotic syndrome are related to pathological typing of nephrosis,and miR-150 may be a potential marker which may differentiate MCD from other subtypes of nephrosis.
Increased Urinary Exosomal Micrornas in Children with Idiopathic Nephrotic Syndrome

Tingting Chen,Cheng Wang,Hanqing Yu,Meng Ding,Cuiping Zhang,Xiaolan Lu,Chen-Yu Zhang,Chunni Zhang

DOI: https://doi.org/10.1016/j.ebiom.2018.11.018

IF: 11.205

2019-01-01

EBioMedicine

Abstract:Background: Urinary exosomal miRNAs are gaining increasing attention for their potential as ideal non-invasive biomarkers for kidney diseases; however, little is known about their diagnostic ability for paediatric nephrotic syndrome (NS). This study explored the clinical value of urinary exosomal miRNAs for paediatric idiopathic NS. Methods: Urine samples were collected from 129 NS children and 126 age-/sex-matched healthy controls. The miRNA profile of urinary exosomes was analysed by high-throughput Illumina sequencing via synthesis (SBS) technology followed by verification with a quantitative reverse-transcription polymerase chain reaction (RTqPCR) assay arranged in two independent cohorts. Additionally, paired urine samples from 65 of these patients were collected before and after treatment. Findings: The Illumina SBS identified 30 markedly increased urinary exosomal miRNAs in NS children compared with controls (>= 5-fold, P < .05). Fifteen miRNAs were selected for further investigation, of which 5 (miR-194-5p, miR-146b-5p, miR-378a-3p, miR-23b-3p and miR-30a-5p) were verified by RT-qPCR to be significantly and steadily increased in NS (>3-fold, P < .01) and markedly reduced during the clinical remission period (P < .001). Moreover, the concentrations of miR-194-5p and miR-23b-3p were significantly positively correlated with the urine protein content and were markedly higher in the high urine protein group than in the low urine protein group (P < .001 and P < .01, respectively). Interpretations: We identified 5 altered urinary exosomal miRNAs in NS children with disease progression and treatment. These urinary exosomal miRNAs could be promising and non-invasive potential biomarker candidates for diagnosing, monitoring and stratifying paediatric NS. Fund: National Natural Science Foundation of China; Fund of State Key Laboratory of Analytical Chemistry for Life Science; National Basic Research Programme of China; Foundation of Jiangsu Provincial Medical Youth Talent. (c) 2018 The Authors. Published by Elsevier B.V.
Decreased Serum miR-503 Level in Children with Nephrotic Syndrome.

Hui Wang,Zhao Hu,Li Chen

DOI: https://doi.org/10.7754/Clin.Lab.2015.150407

IF: 1.053

2015-01-01

Clinical Laboratory

Abstract:Background: Serum microRNAs (miRNA, miR) are suggested to have great potential to serve as biomarkers. In this study, we explored the clinical role of serum miRNAs which may play key roles in childhood nephrotic syndrome (NS). Methods: Serum samples were obtained from 150 NS children and 109 age/gender-matched healthy controls. The levels of serum miRNAs were analyzed using the TaqMan Low Density Array and then validated with RT-qPCR assay. Pathological changes were examined in NS children with immunohistochemical analysis. The effects of miR-503 on cell proliferation and cell cycle were explored using MTT assay and flow cytometry in rat mesangial cells (RMCs). Western blot analysis was applied to determine the effect of miR-503 on cell cycle-related proteins. Results: The concentration of serum miR-503 was highly decreased in NS children compared with controls (p < 0.0001). In NS children, we found obvious enhancement of cell proliferation marker Ki-67 by immunohistochemistry. Moreover miR-503 mimics significantly extended the G0/G1 phase and decreased the G2/M phase in comparison with the negative control group. Overexpression of miR-503 obviously reduced the levels of cyclin E. Luciferase reporter assay revealed that cyclin E was the target of miR-503. Conclusions: In this study, we determined that serum miR-503 was significantly decreased in NS children. MiR-503 contributes to the aberrant proliferation of RMCs by targeting cyclin E, which may represent potential diagnostic and prognostic biomarkers for idiopathic pediatric NS.
Expression of serum microRNA-30a in pediatric nephrotic syndrome and its clinical significance

ZHANG Ying,GAO Chun-lin,XIA Zheng-kun,GAO Yuan-fu,FAN Zhong-min,CAI Xiao-yi,LIU Meng-yuan

2013-01-01

Abstract:ObjectiveTo measure the level of microRNA(miR)-30a in serum of children with nephrotic syndrome,an alyze its correlation with clinical indicators that are used for diagnosis of nephrotic syndrome,and evaluate its role as a diagnostic marker for frequently relapsing nephrotic syndrome(FRNS).MethodsA cohort of 80 children, diagnozed with nephrotic syndrome hospitalized in Department of Pediatrics of Nanjing General Hospital of Nanjing Military Com mand from October 2011 to October 2012,and 30 healthy children as normal control were enrolled in this study. miR NAs were extracted from the serum after adding synthetic cel-miR-39,as extrinsic parameter was spiked. miR-30a lev el was detected by real-time reverse transcription polymerase chain reactions(PCR)with synthetice cel-miR-39 for normalization and synthetice miR-30a for standard curve,and its correlations with clinical indicators were analyzed. Ac cording to absolute quantification of miRNAs calculated by standard curve,receiveer-oprator characteristic curve(ROC)analysis was applied to evaluate the diagnostic ability of miR-30a for frequently relapsing nephrotic syndrome(FRNS).Results(1)The concentration of serum miRNA-30a level was increased in nephrotic syndrome children compared with healthy controls(P<0.01). miRNA-30a level was significantly higher in the FRNS than non-FRNS(P< 0.01).(2)Serum miR-30a inversely correlated with serum albumin,and positively corelated with proteinuria,urine retinol binding protein,and urine N-acetyl-β-glucosaminidase.(3)The ROC curve based on serum miR-30a level was constructed,the area under the curve was 0.895(95% confidence interval,0.827 to 0.986, P<0.001). WhenYouden′s index reached maximum,the sensitivity and specificity of the serum miR-30a were 90.0% and 77.5% respectively.ConclusionOur findings indicated that se rum miR-30a is significantly increased in the NS chil dren,and it correlates with serum albumin,proteinuria,urine retinol binding protein,and urine N-acetyl-β-glucosaminidase. Serum miR-30a has a better diagnostic efficacy for FRNS.
Profiling and Initial Validation of Urinary Micrornas As Biomarkers in IgA Nephropathy

Nannan Wang,Ru Bu,Zhiyu Duan,Xueguang Zhang,Pu Chen,Zuoxiang Li,Jie Wu,Guangyan Cai,Xiangmei Chen

DOI: https://doi.org/10.7717/peerj.990

IF: 3.061

2015-01-01

PeerJ

Abstract:Background. MicroRNAs (miRNAs) have been found in virtually all body fluids and used successfully as biomarkers for various diseases. Evidence indicates that miRNAs have important roles in IgA nephropathy (IgAN), a major cause of renal failure. In this study, we looked for differentially expressed miRNAs in IgAN and further evaluated the correlations between candidate miRNAs and the severity of IgAN.Methods. Microarray and RT-qRCR (real-time quantitative polymerase chain reaction) were sequentially used to screen and further verify miRNA expression profiles in urinary sediments of IgAN patients in two independent cohorts. The screening cohort consisted of 32 urine samples from18 patients with IgAN, 4 patients with MN (membranous nephropathy), 4 patients with MCD (minimal changes disease) and 6 healthy subjects; the validation cohort consisted of 102 IgAN patients, 41 MN patients, 27 MCD patients and 34 healthy subjects. The renal pathological lesions of patients with IgAN were evaluated according to Lee's grading system and Oxford classification.Results. At the screening phase, significance analysis of microarrays analysis showed that no miRNA was differentially expressed in the IgAN group compared to all control groups. But IgAN grade I-II and III subgroups (according to Lee's grading system) shared dysregulation of two miRNAs (miR-3613-3p and miR-4668-5p). At the validation phase, RT-qPCR results showed that urinary level of miR-3613-3p was significantly lower in IgAN than that in MN, MCD and healthy controls (0.47, 0.44 and 0.24 folds, respectively, all P < 0.01 by Mann-Whitney U test); urinary level of miR-4668-5p was also significantly lower in IgAN than that in healthy controls (0.49 fold, P < 0.01). Significant correlations were found between urinary levels of miR-3613-3p with 24-hour urinary protein excretion (Spearman r = 0.50, P = 0.034), eGFR (estimated glomerular filtration rate) (r = -0.48, P = 0.043) and Lee's grades (r = 0.57, P = 0.014). Similarly, miR-4668-5p was significantly correlated with eGFR (r = -0.50, P = 0.034) and Lee's grades (r = 0.57, P = 0.013). For segmental glomerulosclerosis according to Oxford classification, patients scored as S0 had significantly lower levels of urinary miR-3613-3p and miR-4668-5p than those scored as S1 (0.41 and 0.43 folds, respectively, all P < 0.05).Conclusions. The expression profile of miRNAs was significantly altered in urinary sediments from patients with IgAN. Urinary expression of miR-3613-3p was down-regulated in patients with IgAN. Moreover, urinary levels of both miR-3613-3p and miR-4668-5p were correlated with disease severity. Further studies are needed to explore the roles of miR-3613-3p and miR-4668-5p in the pathogenesis and progression of IgA nephropathy.
MicroRNAs and the kidney: coming of age

Samuel Saal,Scott J Harvey

DOI: https://doi.org/10.1097/MNH.0b013e32832c9da2

Abstract:Purpose of review: MicroRNAs (miRNAs) are regulatory RNAs that act as posttranscriptional repressors by binding the 3' untranslated region of target genes. They have been implicated in diverse biologic and pathologic processes and are emerging as important players in kidney health and disease. Here, we review the latest literature in this exciting and rapidly evolving field. Recent findings: Studies of conditional Dicer knockout mice revealed critical roles for miRNAs in orchestrating kidney development and maintaining the structural and functional integrity of the renal collecting system and glomerular barrier. Expression profiling has provided a reasonably clear picture of miRNAs present in normal kidney and pointed to individual miRNAs that may serve special functional roles therein. Specific miRNAs have been implicated in pathways linked to cystic kidney disease (miR-15a), and Wilms' tumor (miR-17-92). Several miRNAs are upregulated by transforming growth factor beta-1 in models of diabetic nephropathy. Some promote matrix deposition (miR-192 and miR-377) or epithelial-to-mesenchymal transition (miR-200 and miR-205), whereas preliminary findings suggest others might serve protective roles (miR-21). miRNAs recently identified in urinary exosomes could potentially serve as disease biomarkers. Summary: Nephrology is in the midst of a miRNA 'revolution' that promises incredible advances in our understanding of genetic regulatory pathways underlying kidney disease, and, with it, new avenues for treatment.
microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential

Zhiwen Liu,Ying Fu,Mingjuan Yan,Subing Zhang,Juan Cai,Guochun Chen,Zheng Dong

DOI: https://doi.org/10.1016/j.pharmthera.2024.108709

IF: 13.4

2024-08-26

Pharmacology & Therapeutics

Abstract:MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating gene expression by inhibiting the translation of their specific target messenger RNAs. To date, numerous studies have demonstrated changes in the expression of miRNAs in the kidneys throughout the progression of both acute kidney injury (AKI) and chronic kidney disease (CKD) in both human patients and experimental models. The role of specific microRNAs in the pathogenesis of kidney diseases has also been demonstrated. Further studies have elucidated the regulation of these microRNAs in diseased kidneys. Besides, certain miRNAs are detected in plasma and/or urine in kidney diseases and are potential diagnostic biomarkers. In this review, we provide an overview of recent developments in our understanding of how miRNAs contribute to kidney diseases. We also explore the potential of miRNAs as both biomarkers and therapeutic targets for these conditions, and highlight future research directions.

pharmacology & pharmacy
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

Mitsuo Kato,Rama Natarajan

DOI: https://doi.org/10.1111/nyas.12758

IF: 6.499

2015-04-15

Annals of the New York Academy of Sciences

Abstract:MicroRNAs (miRNAs) are short noncoding RNAs that regulate gene expression by posttranscriptional and epigenetic mechanisms and thereby affect many cellular processes and disease states. Over 2,000 human mature miRNAs have been identified, and at least 60% of all human protein-coding genes are known to be regulated by miRNAs. MicroRNA biogenesis involves classical transcription regulation and processing by key ribonucleases, as well as other protein factors and epigenetic mechanisms. Diabetic nephropathy (DN), a severe microvascular complication frequently associated with diabetes mellitus, is a major cause of renal failure. Although several mechanisms of regulation of key renal genes implicated in DN pathogenesis have been identified, a greater understanding is needed to develop better treatment modalities. Recent studies show that miRNAs induced in renal cells in vivo and in vitro under diabetic conditions can promote the accumulation of extracellular matrix proteins related to fibrosis and glomerular dysfunction. In this review, we highlight the significance of the expression of miRNAs in various stages of DN and emerging approaches to exploit them as biomarkers for early detection or novel therapeutic targets to prevent progression of DN.

multidisciplinary sciences
The Function of MicroRNAs in Renal Development and Pathophysiology

Liming Ma,Lianghu Qu

DOI: https://doi.org/10.1016/j.jgg.2013.03.002

2013-01-01

Abstract:MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that modulate diverse biological processes predominantly by translation inhibition or induction of mRNA degradation. They are important regulatory elements involved in renal physiology and pathology. Dysregulation of miRNAs disrupts early kidney development, renal progenitor cell differentiation and the maintenance of mature nephrons. miRNAs are also reported to participate in various renal diseases, including chronic kidney disease, acute kidney injury, allograft acute rejection and renal cell carcinoma. Differentially regulated miRNAs may represent innovative biomarkers for diagnosis and prognosis. Therefore, determining the roles of miRNAs in different types of renal diseases will help to clarify the pathogenesis and facilitate the development of novel therapies.
MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application

Linsey J. F. Peters,Jürgen Floege,Erik A. L. Biessen,Joachim Jankowski,Emiel P. C. van der Vorst

DOI: https://doi.org/10.3390/ijms21186547

IF: 5.6

2020-09-07

International Journal of Molecular Sciences

Abstract:There are still major challenges regarding the early diagnosis and treatment of chronic kidney disease (CKD), which is in part due to the fact that its pathophysiology is very complex and not clarified in detail. The diagnosis of CKD commonly is made after kidney damage has occurred. This highlights the need for better mechanistic insight into CKD as well as improved clinical tools for both diagnosis and treatment. In the last decade, many studies have focused on microRNAs (miRs) as novel diagnostic tools or clinical targets. MiRs are small non-coding RNA molecules that are involved in post-transcriptional gene regulation and many have been studied in CKD. A wide array of pre-clinical and clinical studies have highlighted the potential role for miRs in the pathogenesis of hypertensive nephropathy, diabetic nephropathy, glomerulonephritis, kidney tubulointerstitial fibrosis, and some of the associated cardiovascular complications. In this review, we will provide an overview of the miRs studied in CKD, especially highlighting miR-103a-3p, miR-192-5p, the miR-29 family and miR-21-5p as these have the greatest potential to result in novel therapeutic and diagnostic strategies.

biochemistry & molecular biology,chemistry, multidisciplinary
MicroRNAs in chronic pediatric diseases (Review)

Mingyao Zhang,Yanhua Han

DOI: https://doi.org/10.3892/etm.2024.12388

IF: 2.7

2024-01-15

Experimental and Therapeutic Medicine

Abstract:MicroRNAs are small non-coding RNAs with a length of 20-24 nucleotides. They bind to the 3'-untranslated region of target genes to induce the degradation of target mRNAs or inhibit their translation. Therefore, they are involved in the regulation of development, apoptosis, proliferation, differentiation and other biological processes (including hormone secretion, signaling and viral infections). Chronic diseases in children may be difficult to treat and are often associated with malnutrition resulting from a poor diet. Consequently, further complications, disease aggravation and increased treatment costs impose a burden on patients and their families. Existing evidence suggests that microRNAs are involved in various chronic non-neoplastic diseases in children. The present review discusses the roles of microRNAs in five major chronic diseases in children, namely, diabetes mellitus, congenital heart diseases, liver diseases, bronchial asthma and epilepsy, providing a theoretical basis for them to become therapeutic biomarkers in chronic pediatric diseases.

medicine, research & experimental
Identification of Differentially Expressed Micrornas in Acute Kawasaki Disease

Ye Chen,Yue-Yue Ding,Yan Ren,Lei Cao,Qiu-Qin Xu,Ling Sun,Ming-Guo Xu,Hai-Tao Lv

DOI: https://doi.org/10.3892/mmr.2017.8016

IF: 3.423

2018-01-01

Molecular Medicine Reports

Abstract:The present study used microarray analysis to screen the plasma expression of microRNAs (miRNAs) in patients with acute Kawasaki disease (KD) and aimed to explore the pathogenesis of KD. Plasma was collected from children with acute KD (n=6) and from healthy control children (n=6). Total RNA was extracted and differential miRNA expression between the two groups was determined. Differentially expressed miRNAs were validated using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) in an independent cohort (n=8). Target genes of the differentially expressed miRNAs were predicted and analyzed for gene ontology term enrichment and Kyoto Encyclopedia of Genes and Genomes pathways. miRNA microarray analysis revealed that seven miRNAs (miRs) were significantly upregulated (hsa‑let‑7b‑5p, hsa‑miR‑223‑3p, hsa‑miR‑4485, hsa‑miR‑4644, hsa‑miR‑4800‑5p, hsa‑miR‑6510‑5p and hsa‑miR‑765) and three were significantly downregulated (hsa‑miR‑33b‑3p, hsa‑miR‑4443 and hsa‑miR‑4515) in acute KD compared with the healthy controls. hsa‑miR‑223‑3p expression levels detected by RT‑qPCR were consistent with the microarray results. A total of 62 target genes of hsa‑miR‑223‑3p were predicted. In total, 10 differentially expressed miRNAs were identified in acute KD, of which hsa‑miR‑223‑3p was verified by RT‑qPCR.
MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients

Ligia Petrica,Agneta-Maria Pusztai,Mihaela Vlad,Adrian Vlad,Florica Gadalean,Victor Dumitrascu,Daliborca Vlad,Silvia Velciov,Cristina Gluhovschi,Flaviu Bob,Sorin Ursoniu,Maxim Petrica,Petru Matusz,Octavian Cretu,Daniela Radu,Oana Milas,Alina Secara,Anca Simulescu,Roxana Popescu,Dragos Catalin Jianu

DOI: https://doi.org/10.1080/07435800.2019.1690505

2019-11-14

Endocrine Research

Abstract:<span><b>Background</b>: The association of vascular remodeling in the kidney and the brain with a particular microRNAs (miRNA) profile is not well studied.<b>Methods</b>: Seventy-six patients with Type 2 diabetes and 11 healthy subjects were assessed concerning urine albumin: creatinine ratio (UACR), biomarkers of podocyte injury and of proximal tubule (PT) dysfunction. MiRNA were quantified in blood and urine by a real-time PCR System. Cerebrovascular ultrasound measurements were performed in the carotid and middle cerebral arteries.<b>Results</b>: MiRNA21 and miRNA124 correlated positively with nephrin, podocalyxin, synaptopodin, urinary N-acetyl-D-glucosaminidase (NAG), urinary kidney-injury molecule-1 (KIM-1), UACR, and negatively with eGFR; miRNA125a, 126, 146a, 192 correlated negatively with nephrin, podocalyxin, synaptopodin, urinary NAG, urinary KIM-1, UACR, and directly with eGFR. Plasma miRNA-21 and miRNA192 correlated directly with cerebral hemodynamics parameters of atherosclerosis and arteriosclerosis. MiRNA-124, 125a, 126, 146a showed negative correlations with the same parameters.<b>Conclusions</b>: In Type 2 diabetes patients there is an association of vascular remodeling in the brain and the kidney with a specific miRNAs pattern. Cerebrovascular changes occur even in normoalbuminuric patients, with 'high-to-normal' levels of podocyte injury and PT dysfunction biomarkers. These phenomena may be explained by the variability of miRNA expression within the two organs in early DKD.</span>

endocrinology & metabolism
Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

Jianwen Yu,Chaolun Yu,Boya Feng,Xiaojiang Zhan,Ning Luo,Xueqing Yu,Qin Zhou

DOI: https://doi.org/10.1186/s12882-019-1512-x

2019-08-27

BMC Nephrology

Abstract:<h3 class="Heading">Background</h3><p class="Para">Though the roles of microRNAs (miRNAs) in renal diseases have been extensively investigated, a thorough screening and comparison of miRNAs among different types of chronic kidney disease (CKD) has never been performed.</p><h3 class="Heading">Methods</h3><p class="Para">The intrarenal miRNAs were profiled from fresh kidney tissues of patients with biopsy-proven minimal change disease (MCD), focal segmental glomerular sclerosis (FSGS) and diabetic nephropathy (DN) by using microarray. Commonly dysregulated miRNAs were validated by real-time PCR using paraffin-embedded renal tissues from all three types of CKD patients as well as mouse unilateral ureteral obstruction (UUO) model. Two novel miRNAs were selected and annotations of their target genes were performed using GO and KEGG pathway enrichment analysis. Biological functions of three two candidate miRNAs were explored in TGF-β1-induced cell model using human kidney proximal tubular cells (HK-2).</p><h3 class="Heading">Results</h3><p class="Para">The kidney biopsy samples of three disease types represent different levels of damage and fibrosis, which were the mildest in MCD, moderate in FSGS, and the most severe in DN. 116 miRNAs were identified to be commonly dysregulated, including 40 up-regulated and 76 down-regulated in CKD tissues as compared with healthy donor kidney biopsy tissues. Two novel miRNAs, hsa-miR-3607-3p and hsa-miR-4709-3p, were verified as consistently differentially expressed among all three types of patient samples as well as in mouse model. In vitro, hsa-miR-3607-3p was repressed while hsa-miR-4709-3p was induced by TGF-β1 treatment. Inhibition of hsa-miR-3607-3p or overexpression of hsa-miR-4709-3p promoted TGF-β1-induced migration and F-actin assembling in HK-2 cells, which are characteristics of epithelial–mesenchymal transition (EMT). Further study identified that ITGB8 and CALM3 were the bona fide target genes of hsa-miR-3607-3p and hsa-miR-4709-3p respectively.</p><h3 class="Heading">Conclusions</h3><p class="Para">The present identify a unique miRNAs profile that probably relates to the common fibrosis process of CKD. Results of our study suggest that hsa-miR-3607-3p and hsa-miR-4709-3p may represent as promising therapeutic targets against kidney fibrosis.</p>

urology & nephrology
Study on the Levels and Clinical Significance of Serum miR-150 in Children with Nephrotic Syndrome

Yuan-yuan ZHU,Yang LUO,Wan-jian GU,Cheng WANG,Wei SUN,Chun-ni ZHANG

DOI: https://doi.org/10.3969/j.issn.1671-7414.2017.06.002

2017-01-01

Abstract:Objective To investigate the levels and clinical significance of serum miR-150 in children with primary nephrotic syndrome(NS).Methods Serum samples were collected from 78 NS children and 79 age-and sex-matched control children in Nanjing General Hospital,Jiangsu Province Hospital of TCM and Nanjing Children Hospital from March 2010 to May 2014.Quantitive Real-time PCR(qRT-PCR)assays were used to determine the concentrations of serum miR-150 in NS and control children.The other lipid and renal function parameters including serum TP,ALB,GLO,TC,TG,Urea,Cr,Uric acid and Uric protein were also assessed.Statistical analyzes were used to evaluate the clinical value of serum miR-150 for NS as well as to assess the clinical association between the levels of serum miR-150 and other clinical parameters.Results The ser-um levels of miR-150 were significantly elevated in NS children[101.4(21.29~336.6)fmol/L(F=3.658,P<0.001)]as compared with controls[34.11(5.53~134.2)fmol/L].ROC curve analysis showed that the area under the receiver operat-ing characteristic curve(AUCROC)was 0.892(95% CI=0.843~0.940).Spearman rank correlations analyzes showed that the levels of serum miR-150 were significantly negatively associated with GLO(r=-0.231,P=0.042)and TG(r=-0.233,P=0.040)in NS children.Multiple linear regression analyses showed that serum miR-150 was independently associ-ated with serum ALB levels(β=0.241,P=0.034;adjusted r2=0.046)after adjustment of other related factors.Further-more,multivariate logistic regression analysis showed that serum miR-150 an independent risk factor for NS after adjusting other factors including age and gender[OR=16.07(95% CI=5.35~48.28),P<0.001].Conclusion The serum levels of miR-150 were markedly elevated in NS children and closely associated with with impaired kidney function as well as lipid pa-rameters,and may have the potential as a novel auxiliary diagnosis marker for assessing the development of NS.
Urinary MicroRNA biomarkers of nephrotoxicity in Macaca fascicularis

Subham Dasgupta,Tatiana Sharapova,Prathap K Mahalingaiah,Brian N Chorley,Ahmed Shoieb,Takayuki Tsuji,Alef A C Dos Santos,Rohit Chari,Ali Ebrahimi,Deidre A Dalmas Wilk,Syril Pettit,Bhupinder Bawa,Erin Vaughan,Terry R van Vleet,Constance A Mitchell,Peter S T Yuen

DOI: https://doi.org/10.1016/j.yrtph.2024.105668

Abstract:Drug-induced kidney injury (DIKI) refers to kidney damage resulting from the administration of medications. The aim of this project was to identify reliable urinary microRNA (miRNAs) biomarkers that can be used as potential predictors of DIKI before disease diagnosis. This study quantified a panel of six miRNAs (miRs-210-3p, 423-5p, 143-3p, 130b-3p, 486-5p, 193a-3p) across multiple time points using urinary samples from a previous investigation evaluating effects of a nephrotoxicant in cynomolgus monkeys. Exosome-associated miRNA exhibited distinctive trends when compared to miRNAs quantified in whole urine, which may reflect a different urinary excretion mechanism of miRNAs than those released passively into the urine. Although further research and mechanistic studies are required to elucidate how these miRNAs regulate signaling in disease pathways, we present, for the first time, data that several miRNAs displayed strong correlations with histopathology scores, thus indicating their potential use as biomarkers to predict the development of DIKI in preclinical studies and clinical trials. Also, these findings can potentially be translated into other non-clinical species or human for the detection of DIKI.

MicroRNAs in idiopathic childhood nephrotic syndrome

Differentially Expressed Micrornas in Kidney Biopsies from Various Subtypes of Nephrotic Children.

Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Differential Expression Of Urinary Exosomal Small Rnas In Idiopathic Membranous Nephropathy

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Increased Urinary Exosomal Micrornas in Children with Idiopathic Nephrotic Syndrome

Decreased Serum miR-503 Level in Children with Nephrotic Syndrome.

Expression of serum microRNA-30a in pediatric nephrotic syndrome and its clinical significance

Profiling and Initial Validation of Urinary Micrornas As Biomarkers in IgA Nephropathy

MicroRNAs and the kidney: coming of age

microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential

MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

The Function of MicroRNAs in Renal Development and Pathophysiology

MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application

MicroRNAs in chronic pediatric diseases (Review)

Identification of Differentially Expressed Micrornas in Acute Kawasaki Disease

MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

Study on the Levels and Clinical Significance of Serum miR-150 in Children with Nephrotic Syndrome

Urinary MicroRNA biomarkers of nephrotoxicity in Macaca fascicularis